Ipamorelin is a synthetic peptide that acts as a growth hormone secretagogue by selectively binding to growth hormone secretagogue receptors (GHSRs) in the pituitary gland. This action triggers a series of intracellular signaling events that ultimately lead to an increase in the release of growth hormones. Ipamorelin has been studied for its potential therapeutic applications, including in the treatment of growth hormone deficiency, age-related decline in growth hormone production, and as an adjunct therapy for promoting weight loss and muscle building. Its selective action has been observed to increase muscle mass, reduce body fat, improve recovery, and delay aging without the unwanted side effects associated with other growth hormone therapies.